Cedric Laedermann is a Clinical Research Scientist (Medical Advisor) at Eli Lilly and Company, where they currently apply their extensive background in neuroscience to advance medical initiatives. Cedric previously held roles as a Postdoctoral Fellow at CHUV and Boston Children's Hospital, investigating pain mechanisms and drug effects using advanced techniques such as CRISPR/Cas9 and electrophysiology. They earned a Ph.D. in Neuroscience from the Université de Lausanne, focusing on sodium channels and neuropathic pain. Cedric also served as a Drug Discovery Scientist and a Medical Scientific Liaison, building partnerships and leading medical projects in the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices